跳至主要内容
临床试验/IRCT2016082829556N1
IRCT2016082829556N1已完成2 期

Aspirin as an augmenting to Sertraline for treating major depressive disorder, a randomized double blind placebo controlled clinical trial

Vice chancellor for research of Kashan University of Medical Sciences and Health Servisces,Kashan0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40 years 至 80 years(—)
性别
All

入选标准

  • patients with major depressive disorder according to DSM-VI, both gender, and aged between 40 and 80 years old, Consent to participate in the study by completing the informed consent form, Having risk factors for coronary heart disease or stroke. Exclusion criteria: Depression due to physical illness or drug use, A history of gastric ulcers and contraindications for taking aspirin, pregnant women, History of alcohol and substance abuse within 6 months prior to the beginning of the study, positive history of mania, mental retardation, psychosis, using another antidepressant within 4 weeks prior to starting ASA, Candidates for other treatments such as ECT for depression.

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research of Kashan University of Medical Sciences and Health Servisces,Kashan

相似试验